Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic

NCT02818569 is registered in ClinicalTrials.gov with Massachusetts General Hospital as lead sponsor.

NCT NCT02818569
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02818569 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Repurposing Dexmedetomidine as an Orally Administered Sleep Therapeutic
Lead sponsor
Massachusetts General Hospital
Phase
Phase 1/2
Overall status
Completed
Start date
October 31, 2016
Completion date
June 30, 2018
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

insomnia, sleep